MEDICUS SCIENCES ACQUISITION - *W EXP 02/12/202 (MSACW)

CUSIP: G5960S124

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / *W EXP 02/12/202
Total 13F shares
259,143
Share change
-11,110
Total reported value
$26,256
Price per share
$0.09
Number of holders
7
Value change
-$3,000
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP G5960S124?
CUSIP G5960S124 identifies MSACW - MEDICUS SCIENCES ACQUISITION - *W EXP 02/12/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDICUS SCIENCES ACQUISITION - *W EXP 02/12/202 (MSACW) as of Q3 2022

As of 30 Sep 2022, MEDICUS SCIENCES ACQUISITION - *W EXP 02/12/202 (MSACW) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 259,143 shares. The largest 7 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., SILVERARC CAPITAL MANAGEMENT, LLC, Kepos Capital LP, Affinity Asset Advisors, LLC, Knott David M Jr, Ayrton Capital LLC, and Cruiser Capital Advisors, LLC. This page lists 7 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.